APA (7th ed.) Citation

V, M., S, H., E, Z., E, T., E, M., I, S., . . . E, Z. (2018). Combination therapy as a potential risk factor for the development of type 2 diabetes in patients with schizophrenia: The GOMAP study. BMC psychiatry, 18(1), 249. https://doi.org/10.1186/s12888-018-1826-4

Chicago Style (17th ed.) Citation

V, Mamakou, et al. "Combination Therapy as a Potential Risk Factor for the Development of Type 2 Diabetes in Patients with Schizophrenia: The GOMAP Study." BMC Psychiatry 18, no. 1 (2018): 249. https://doi.org/10.1186/s12888-018-1826-4.

MLA (9th ed.) Citation

V, Mamakou, et al. "Combination Therapy as a Potential Risk Factor for the Development of Type 2 Diabetes in Patients with Schizophrenia: The GOMAP Study." BMC Psychiatry, vol. 18, no. 1, 2018, p. 249, https://doi.org/10.1186/s12888-018-1826-4.